ACTONEL COMBI

This brand name is authorized in France, Ireland, United Kingdom

Active ingredients

The drug ACTONEL COMBI contains a combination of these active pharmaceutical ingredients (APIs):

1 Risedronic acid UNII HU2YAQ274O - RISEDRONATE SODIUM HEMI-PENTAHYDRATE

Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved. Read about Risedronic acid

2 Calcium carbonate UNII H0G9379FGK - CALCIUM CARBONATE

Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement. Read about Calcium carbonate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M05BB02	Risedronic acid and calcium, sequential	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BB Bisphosphonates, combinations
Discover more medicines within M05BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 64566299
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 132090
Country: IE	Health Products Regulatory Authority	Identifier(s): 10603